ClinicalTrials.gov
ClinicalTrials.gov Menu

Help Arthritis With Exercise in West Virginia (HARE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00526201
Recruitment Status : Completed
First Posted : September 10, 2007
Last Update Posted : December 24, 2015
Sponsor:
Collaborator:
West Virginia University
Information provided by (Responsible Party):
Jennifer Hootman, Centers for Disease Control and Prevention

Brief Summary:
The purpose of this project is to determine if an evidence-based, community-delivered physical activity program, EnhanceFitness, yields benefits for participants with arthritis. The 3-year project will: 1) conduct a meta-analysis of community-based exercise programs for adults, 2) implement and evaluate the EnhanceFitness program in West Virginia using a randomized, controlled (wait list) design, and 3) disseminate the results to community and public health partners. It is anticipated that participation in the EnhanceFitness program will result in reduced pain, improved physical function and physical activity levels for adults with arthritis.

Condition or disease Intervention/treatment Phase
Arthritis Behavioral: 12-weeks EnhanceFitness Behavioral: Control Phase 3

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 323 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Arthritis Benefits of a Physical Activity Program in West Virginia: Evaluation of EnhanceFitness
Study Start Date : May 2009
Actual Primary Completion Date : January 2011
Actual Study Completion Date : January 2011

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Exercise
Subjects will be randomized to exercise (12 week EnhanceFitness class) or a wait-list control group.
Behavioral: 12-weeks EnhanceFitness
EnhanceFitness class for 12 weeks, 3 times per week for 1 hour sessions.

Control
Wait-list control group will receive intervention after 12-weeks.
Behavioral: Control
Participants randomized to the wait-list control group will continue their regular activities for 12 weeks and then be offered the exercise intervention (EnhanceFitness).




Primary Outcome Measures :
  1. Pain Severity [ Time Frame: 8 months ]
  2. Physical activity level [ Time Frame: 8 months ]
  3. Physical Function [ Time Frame: 8 months ]

Secondary Outcome Measures :
  1. Health-related quality of life [ Time Frame: 8 months ]
  2. Arthritis self-efficacy [ Time Frame: 8 months ]
  3. Self-efficacy for exercise [ Time Frame: 8 months ]
  4. Exercise perceptions [ Time Frame: 8 months ]
  5. Social support [ Time Frame: 8 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 18 and older
  • Any type of self-reported, doctor-diagnosed arthritis

Exclusion Criteria:

  • Any co-existing conditions where exercise is a contraindicated
  • Impaired cognitive status
  • Non-ambulatory

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00526201


Locations
United States, West Virginia
West Virginia University
Morgantown, West Virginia, United States, 26506-9196
Sponsors and Collaborators
Jennifer Hootman
West Virginia University
Investigators
Principal Investigator: Dina L Jones, PT, PHD West Virginia University
Study Director: Jennifer M Hootman, PhD Centers for Disease Control and Prevention

Responsible Party: Jennifer Hootman, Epidemiologist, Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier: NCT00526201     History of Changes
Other Study ID Numbers: CDC-NCCDPHP-AAMC-0944
AAMC-0944
First Posted: September 10, 2007    Key Record Dates
Last Update Posted: December 24, 2015
Last Verified: December 2015

Keywords provided by Jennifer Hootman, Centers for Disease Control and Prevention:
Arthritis
Osteoarthritis
Rheumatoid Arthritis
Fibromyalgia
Lupus

Additional relevant MeSH terms:
Arthritis
Joint Diseases
Musculoskeletal Diseases